

Kalmegh (Andrographis paniculata (Burm.f.) Nees) Growing, Care, Problems & Uses
Problems & Diseases
Introduction
Andrographis paniculata (Burm.f.) Nees, known widely as kalmegh or Green Chiretta or king of bitters, belongs to the family Acanthaceae and is native to South and Southeast Asia. Its defining trait is an extraordinary concentration of andrographolide, a bicyclic diterpenoid lactone of exceptional bitterness and potent immunomodulatory activity, which has made this herbaceous annual one of the most intensively studied medicinal plants in the Asian pharmacopoeia.
Classification
- Plant Type
- Herb
- Lifecycle
- Annual
- Leaf Habit
- Deciduous
- Native Region
- South Asia, Southeast Asia
- Plant Family
- Acanthaceae
In its native ecosystems — moist deciduous forests, disturbed roadsides, and scrubland margins across India, Sri Lanka, and Indochina — A. paniculata functions as a gap-colonising annual, exploiting disturbed ground and seasonal moisture. Its rapid biomass accumulation and prolific seed set allow populations to establish quickly, while its allelopathic root exudates may suppress competing vegetation in dense stands.
Cultivated extensively across India, China, Thailand, Malaysia, and increasingly in parts of Africa and Latin America, kalmegh is a cornerstone of Ayurvedic, Siddha, Traditional Chinese Medicine, and Thai traditional medicine systems. Commercial demand for standardised andrographolide extracts has grown substantially with interest in immunostimulant supplements, placing pressure on wild populations in some regions. This profile covers taxonomy, morphology, phytochemistry, ecology, distribution, and conservation status.
Classification and Taxonomy
Accepted Name and Synonymy
| Field | Value | Notes |
|---|---|---|
| Accepted Scientific Name | Andrographis paniculata (Burm.f.) Nees | Authority: Nees, 1832 |
| Known Synonyms | Justicia paniculata Burm.f.; Andrographis subspicata Wight; Justicia stricta Lam. | See POWO for full synonym list |
| Taxonomic Authority Source | Plants of the World Online (POWO) | Accepted per Kew Gardens POWO database |
| Assessment Date | 2026-04-15 | — |
Classification Hierarchy
| Rank | Taxon |
|---|---|
| Kingdom | Plantae |
| Division | Tracheophyta |
| Class | Magnoliopsida |
| Order | Lamiales |
| Family | Acanthaceae |
| Subfamily | Andrographidoideae |
| Genus | Andrographis |
| Species | Andrographis paniculata (Burm.f.) Nees |
Quick Reference
| Field | Value | Notes |
|---|---|---|
| Common Name(s) | Green Chiretta,Kalmegh; Green Chiretta; King of Bitters; Creat; Hempedu Bumi (Malay); Chuan Xin Lian (Chinese); Bhui-neem (Hindi) | Regional names vary widely |
| Plant Type | Herbaceous annual forb | — |
| Lifecycle | Annual | Completes lifecycle in one growing season |
| Native Range | Indian subcontinent, Sri Lanka, Indochina, southern China | Widely naturalised beyond native range |
| USDA Hardiness Zones | 10–12 (perennial); zones 8–9 as warm-season annual | Frost-sensitive |
| Toxicity Summary | Low toxicity at therapeutic doses; hepatotoxic potential at suprapharmacological doses in animal studies; reproductive toxicity documented in male animal studies at high doses | See T16 |
| IUCN Status | Least Concern (LC) | Assessed 2019 |
| Research Coverage Level | HIGH | Extensive phytochemical and pharmacological literature |
Cytogenetics
Cytogenetics
| Field | Value | Notes |
|---|---|---|
| Chromosome Number (2n) | 2n = 50 | Reported in multiple cytological studies |
| Ploidy Level | Diploid | — |
| Genome Size | Not documented at species level — genus-level data unavailable | Manual research recommended |
| Karyotype Description | Chromosomes small; karyotype analysis indicates relatively symmetrical chromosome complement | Limited detailed karyotype studies available |
| Cytological Stability | Stable; no documented polyploid series within species | — |
Scientific Stability and Nomenclature
Scientific Stability
| Field | Value | Notes |
|---|---|---|
| Nomenclatural Stability | Stable | No competing current accepted authorities |
| Current Accepted Authority | (Burm.f.) Nees, 1832 | Consistent across POWO, IPNI, Flora of India |
| Major Reclassification Events | Original description as Justicia paniculata by Burman f. (1768); transferred to Andrographis by Nees (1832); placement in Andrographidoideae (Acanthaceae) confirmed by molecular phylogenetic work in the 2000s | Subfamily circumscription refined post-molecular study but genus and species epithets unchanged |
Growth Habit and Architecture
| Field | Value | Notes |
|---|---|---|
| Growth Form | Erect herbaceous annual | Stems sharply quadrangular |
| Height at Maturity | 30–110 cm (12–43 in) | Height varies substantially with soil fertility and moisture |
| Stem Morphology | Quadrangular; dark green; glabrous to slightly pubescent; prominently winged at angles | Characteristic feature for identification |
| Branching Pattern | Opposite, extensively branched; branches arise at roughly equal angles | Sympodial branching tendency |
| Root Architecture | Taproot with fibrous laterals; moderately deep | See T11 |
| Leaf Arrangement | Opposite decussate | — |
| Canopy Spread | 20–60 cm (8–24 in) | Varies with branching intensity |
| Surface Features | Leaves petiolate, glabrous above, slightly pubescent on veins below; stems glabrous | — |
| Growth Rate | Fast; full canopy achieved within 60–90 days under optimal conditions | — |
| Seasonal Behaviour | Vegetative growth followed by terminal and axillary paniculate inflorescences; dies back after seed set | Annual senescence post-reproduction |
Leaves

| Field | Value | Notes |
|---|---|---|
| Presence | Present | — |
| Leaf Type | Simple, petiolate; lanceolate to ovate-lanceolate | — |
| Size (length × width) | 3–12 cm × 1–3.5 cm (1.2–4.7 in × 0.4–1.4 in) | Leaves on main stem larger than on lateral branches |
| Colour | Dark green adaxially; paler abaxially | — |
| Arrangement | Opposite decussate | — |
| Special Features | Leaves intensely bitter due to andrographolide content; margin entire to slightly undulate; apex acuminate; base cuneate; venation pinnate | Bitterness detectable in fresh leaves |
Flowers

| Field | Value | Notes |
|---|---|---|
| Inflorescence Type | Paniculate racemes; terminal and axillary | Lax, open panicles |
| Flower Size | 8–12 mm (0.3–0.5 in) long | Small, tubular-bilabiate |
| Petal Colour | White to pale pinkish-white; lower lip with purple-violet streaks and spots | Characteristic lip markings |
| Corolla Form | Bilabiate; 2-lipped; upper lip narrow entire; lower lip 3-lobed | Typical Acanthaceae bilabiate form |
| Calyx | 5 deeply divided sepals; linear-lanceolate; glandular pubescent | — |
| Stamens | 2 fertile stamens; anthers pubescent at base | Reduced stamen number typical of Acanthaceae |
| Pistil | Bicarpellate; style filiform; stigma simple | — |
| Ovary Type | Superior; 2-locular | — |
| Floral Symmetry | Zygomorphic (bilaterally symmetrical) | — |
| Flowering Period | Varies by latitude; see T26 | — |
Fruit

| Field | Value | Notes |
|---|---|---|
| Fruit Type | Capsule; linear-oblong; loculicidal dehiscent | Explosive dehiscence at maturity |
| Fruit Size | 1.5–2.5 cm × 0.3–0.5 cm (0.6–1.0 in × 0.1–0.2 in) | — |
| Fruit Colour at Maturity | Dark brown to blackish | Green when immature |
| Wall Texture | Thin, papery; compressed laterally | — |
| Seeds per Fruit | 8–16 | — |
| Dispersal Mechanism | Ballistic/explosive dehiscence; secondary wind and water dispersal | Capsule walls contract on drying, ejecting seeds |
| Fruit Development Period | Approximately 3–5 weeks post-anthesis | — |
| Harvest Indicator | Capsule turns brown; before full dehiscence for seed collection | — |
| Economic Significance | Whole aerial plant harvested; fruit and seed contribute to andrographolide load | Harvested pre-full-bloom for maximum andrographolide yield |
| Notes | Capsules sharply compressed; characteristic diagnostic feature | — |
Seeds

| Field | Value | Notes |
|---|---|---|
| Seed Type | Endospermic; subquadrate to oblong | — |
| Seed Size | 1.5–3 mm × 1–1.5 mm | Small |
| Seed Colour | Pale yellowish-brown to brown | — |
| Seed Surface | Finely reticulate | — |
| Seed Weight (1,000 seed) | Approximately 0.6–1.2 g | Varies by provenance |
| Dormancy Class | Non-deep physiological dormancy; or non-dormant | Seeds germinate readily after dispersal |
Root System
| Field | Value | Notes |
|---|---|---|
| Root Architecture | Primary taproot with extensive fibrous laterals | Not deep-rooted; roots generally confined to upper 30–50 cm of soil |
| Rooting Depth | 20–50 cm (8–20 in) under typical conditions | Shallower in compacted or waterlogged soils |
| Special Features | Not documented as nitrogen-fixing; no documented specialised root structures (e.g., haustoria, pneumatophores) | Mycorrhizal associations documented — see T30 |
Cultivar Summary
| Cultivar | Key Characteristic | Origin / Notes |
|---|---|---|
| ‘Anand-1’ | High andrographolide content (>2.5% dry weight); improved yield | Developed by Anand Agricultural University, India |
| ‘CIM-Megha’ | Elevated andrographolide and neoandrographolide yields; erect habit | CSIR-CIMAP, India; bred for commercial cultivation |
| ‘Kalpasi’ | Early maturity; adapted to South Indian conditions | Tamil Nadu Agricultural University, India |
| ‘IC-111454’ | Broad adaptability; disease-tolerant accession | NBPGR, India germplasm accession |
| ‘Salam’ | Adapted to Malaysian conditions; consistent biomass | Malaysia; selected for tropical lowland cultivation |
Full variety and cultivar listings are covered in the Varieties and Cultivars guide.
Functional Traits
| Trait | Description | Significance |
|---|---|---|
| C3 Photosynthesis | Fixes CO₂ via the Calvin cycle using RuBisCO; operates under standard mesophytic conditions without nocturnal CO₂ storage; susceptible to photorespiration under high temperature and low humidity | Standard pathway for humid tropical/subtropical annual forbs; limits productivity under severe drought |
| Rapid Annual Growth Strategy | Allocates resources preferentially to leaf and stem biomass during vegetative phase, then shifts allocation sharply to reproduction post-flower initiation; completes full lifecycle in 90–150 days | Enables colonisation of seasonal and disturbed habitats; supports high-density cultivation cycles |
| Andrographolide Biosynthesis | Produces bicyclic diterpenoid lactones via the methylerythritol phosphate (MEP) plastidic pathway; andrographolide accumulates principally in leaves and aerial stems, increasing under stress and with ontogenetic maturity | Primary bioactive metabolite; concentration peaks pre-anthesis, providing optimal harvest timing signal |
| Inducible Defence Chemistry | Upregulates andrographolide and related lactones in response to herbivory and pathogen attack through jasmonate-mediated signalling; wounding experiments show 20–40% increases in diterpenoid concentration | Reduces palatability to generalist herbivores; contributes to field pest resistance |
| Allelopathic Exudation | Root exudates contain andrographolide and other terpenoids that suppress germination and early growth of competing plant species under laboratory conditions | May contribute to competitive dominance in dense crop stands; ecological significance in natural habitats not fully quantified |
| Drought-Responsive Stomatal Control | Closes stomata rapidly in response to water deficit via ABA-mediated guard cell turgor loss; reduces net CO₂ assimilation rate under moderate drought stress | Provides short-term resilience but reduces productivity under sustained water deficit; important for irrigation scheduling |
| Indeterminate Flowering | Inflorescences continue to develop over an extended period rather than simultaneously; axillary and terminal panicles flower sequentially | Extends pollinator access window; produces asynchronous seed maturation requiring staged harvest in commercial production |
| Phenotypic Plasticity in Leaf Morphology | Leaf size, shape, and andrographolide content vary substantially under different light, water, and nutrient regimes; understory plants produce larger, thinner leaves with reduced diterpenoid load compared to open-grown plants | Affects standardisation of medicinal raw material; open-field cultivation in high solar radiation recommended for maximum yield |
| Rapid Canopy Closure | High leaf area index achieved within 45–60 days under fertile conditions; suppresses weed competition through shading | Reduces herbicide need in commercial cultivation; important agronomic trait |
Phytochemistry
| Compound Class | Representative Compounds | Plant Part | Functional / Mechanism | Source |
|---|---|---|---|---|
| Diterpenoid lactones | Andrographolide; neoandrographolide; 14-deoxyandrographolide | Leaves, stems | NF-κB pathway inhibition; anti-inflammatory and immunomodulatory activity via cytokine suppression | Burgos et al. (2009); Jayakumar et al. (2013) |
| Flavonoids | Apigenin; luteolin; andrographidine A–F | Leaves | Antioxidant activity via ROS scavenging; modulation of oxidative stress pathways | Pholphana et al. (2004); Mishra et al. (2007) |
| Xanthones | 1,8-dihydroxy-3,7-dimethoxyxanthone | Roots, leaves | Cytoprotective and antioxidant roles via phenolic redox activity | Koteswara Rao et al. (2004) |
| Phenolic acids | Chlorogenic acid; caffeic acid; ferulic acid | Aerial parts | Free radical scavenging; contributes to anti-inflammatory response | Mishra et al. (2007) |
| Phytosterols | β-sitosterol; stigmasterol | Roots, stems | Membrane stabilisation; anti-inflammatory modulation | Reddy et al. (2012) |
| Alkaloids | Andrographine; panicoline | Roots | Minor bioactive role; limited evidence of neuroactive effects | Jarukamjorn & Nemoto (2008) |
Phytochemical Organ Distribution
| Organ | Compound Class | Representative Compound | Concentration | Source |
|---|---|---|---|---|
| Leaf | Diterpenoid lactone | Andrographolide | 0.5–6.0% dry weight | Jayakumar et al. (2013) |
| Leaf | Flavonoid | Apigenin, luteolin | 0.1–0.5% dry weight (combined flavonoids) | Pholphana et al. (2013) |
| Stem (aerial) | Diterpenoid lactone | Neoandrographolide; 14-deoxyandrographolide | Lower than leaf; approximately 30–60% of leaf concentration | Calabrese et al. (2000) |
| Root | Xanthone | 1,8-dihydroxy-3,7-dimethoxyxanthone | Minor fraction; quantitative data limited | Koteswara Rao et al. (2004) |
| Root | Alkaloid | Andrographine | Trace; <0.05% dry weight estimated | Bhavana et al. (2016) |
| Whole aerial plant | Polyphenol | Chlorogenic acid | 0.1–0.3% dry weight | Mishra et al. (2009) |
| Leaf and stem | Terpenol | β-sitosterol | Present; quantitative data varies by provenance | Reddy et al. (2012) |
Nutritional Composition (T15)
| Nutrient | Value per 100 g (dry weight) | Notes | Source |
|---|---|---|---|
| Energy | Not established | Medicinal herb; not consumed as staple food | WHO Monograph (2002); IPC (2018) |
| Carbohydrates | Not established | Primary biomass component; not nutritionally profiled | WHO Monograph (2002) — absence of compositional data |
| Protein | Not established | Minor component in aerial biomass | WHO Monograph (2002) — absence of compositional data |
| Dietary Fiber | Not established | Likely present; not quantified for species | WHO Monograph (2002) — absence of compositional data |
| Total Fat | Not established | Very low in leafy biomass | WHO Monograph (2002) — absence of compositional data |
| Minerals | Not established | Trace minerals present; no standardised profile | WHO Monograph (2002) — absence of compositional data |
| Vitamins | Not established | No validated compositional dataset available | WHO Monograph (2002) — absence of compositional data |
| Water Content | Not applicable (dry medicinal material basis) | Values vary widely in fresh samples | IPC (2018) |
Toxicity and Safety
| Subject | Toxic Compounds | Clinical Effects | Source |
|---|---|---|---|
| Humans | Andrographolide (high dose) | Generally safe at therapeutic doses (100–400 mg/day); adverse effects include headache, fatigue, gastrointestinal upset; rare hepatotoxicity at high doses; contraindicated in pregnancy due to antifertility effects | WHO (2002); Burgos et al. (2009) |
| Cats | Not established | No species-specific studies; safety not established | WHO (2002) |
| Dogs | Not established | No controlled studies; caution due to diterpenoid activity | WHO (2002) |
| Livestock | Andrographolide (high dose) | Antifertility effects observed in animal studies; avoid excessive intake | Burgos et al. (2009) |
Native Range and Distribution

| Field | Value | Notes |
|---|---|---|
| Primary Native Range | Indian subcontinent (India, Sri Lanka, Bangladesh, Pakistan borders); Indochina (Myanmar, Thailand, Laos, Vietnam, Cambodia); Peninsular Malaysia; southern China (Yunnan, Guangdong) | Core distribution; species is native to moist tropical and subtropical regions of South and Southeast Asia |
| Elevation Range | Sea level to approximately 1,000 m (3,280 ft) | Most abundant below 500 m; records up to 1,600 m in India |
| Biogeographic Region | Indomalayan realm | — |
| Naturalised Range | Sub-Saharan Africa (Tanzania, Nigeria, Cameroon); Caribbean (Cuba, Puerto Rico); parts of tropical Latin America (Brazil, Peru); Pacific Islands | Widely naturalised following deliberate introduction for medicinal cultivation |
| Range Dynamics | Range expanding with increasing commercial cultivation and deliberate introduction; not documented as invasive in GBIF or IUCN invasive species databases at global level | Some naturalisations in Africa and the Americas confirmed via herbarium records |
Global Cultivation and Naturalization
| Region | Status | Notes |
|---|---|---|
| India | Extensively cultivated; major commercial producer | Andhra Pradesh, Gujarat, West Bengal, Tamil Nadu principal production states |
| China | Cultivated commercially; Yunnan, Guangdong, Fujian | Major exporter of standardised extract |
| Thailand | Cultivated and wild-harvested; integrated into national herbal medicine policy | Listed on Thai National List of Essential Medicines |
| Malaysia and Indonesia | Cultivated and semi-wild; significant domestic herbal market | Hempedu bumi widely sold in pharmacies |
| Vietnam | Cultivated; used in traditional and institutional medicine | COVID-19 period saw sharp demand increase |
| Sub-Saharan Africa | Limited commercial cultivation; mainly Tanzania and Nigeria | Introduced for malaria adjunct research programmes |
| Latin America | Small-scale cultivation; Brazil, Peru | Growing export market; limited data |
| Europe and North America | Not field cultivated commercially; grown as glasshouse or annual in botanical research institutions | Supplement imports dominant |
Natural Habitat
| Field | Value | Notes |
|---|---|---|
| Primary Habitat | Moist deciduous forest margins; disturbed roadsides; scrubland; waste ground; secondary vegetation | Gap coloniser and ruderal species |
| Soil Preference | Loamy to sandy-loam; well-drained; moderate organic matter | Tolerates poorer soils |
| Moisture Regime | Seasonally moist; tolerates short dry periods | Does not persist in waterlogged or swampy sites |
| Light Environment | Full sun to partial shade; highest biomass and andrographolide under full sun | Shade-adapted populations produce lower diterpenoid yields |
| Associated Vegetation | Often found with other Acanthaceae, annual grasses, and pioneer forbs in disturbed habitats; forest margin species | Not a closed-canopy forest interior species |
| Altitudinal Distribution | Predominantly lowland to submontane; sea level to approximately 1,000 m | Occasional records to 1,600 m in India |
Ecological Role
| Role | Description | Notes |
|---|---|---|
| Herbivore Interactions | Diterpenoid lactone content deters generalist herbivores; specialist insects in Acanthaceae, including some chrysomelid and pyralid species, are documented associates | High andrographolide concentration functions as effective anti-feedant against most generalist insects |
| Soil and Pioneer Ecology | Functions as fast-growing gap coloniser; rapid canopy closure suppresses competing seedlings; root exudates with documented allelopathic activity in laboratory conditions | Contributes to early succession dynamics on disturbed ground |
| Seed and Nutrient Cycling | Explosive capsule dehiscence contributes to localised seed rain; annual biomass adds organic matter to soil on decomposition | Biomass nitrogen content supports local nutrient cycling in cultivated settings |
Optimal Climate Parameters
| Parameter | Optimal Range | Tolerance Range | Notes |
|---|---|---|---|
| Mean Annual Temperature | 22–28°C (72–82°F) | 18–35°C (64–95°F) | Best growth and andrographolide accumulation in warm humid tropics |
| Daytime Temperature | 25–32°C (77–90°F) | 20–38°C (68–100°F) | Temperatures above 38°C cause growth depression |
| Nighttime Temperature | 18–24°C (64–75°F) | 12–28°C (54–82°F) | Chilling injury below 10°C; frost kills plants |
| Annual Rainfall | 1,000–2,500 mm (39–98 in) | 600–3,500 mm (24–138 in) | Tolerates seasonal dry periods of up to 3 months if established; waterlogging damaging |
| Dry Season Length | Up to 3 months | Up to 5 months with supplemental irrigation | Yield and andrographolide content reduced under extended drought |
| Relative Humidity | 60–85% | 40–95% | Very high humidity (>90%) over extended periods increases fungal disease risk |
| Solar Radiation | Full sun; 6–8 hours direct insolation daily | 4–10 hours | Andrographolide content positively correlated with solar radiation intensity; shade reduces bioactive yield |
Stress Tolerance Profile
| Stress Type | Tolerance Level | Physiological Response | Notes |
|---|---|---|---|
| Drought | Moderate | Rapid stomatal closure via ABA signalling reduces water loss; leaf rolling and wilting at moderate deficit; growth cessation under severe deficit; does not recover fully from extended severe drought | Tolerates short dry spells when established; irrigation recommended in commercial cultivation |
| Heat | Moderate-High | Maintains photosynthesis up to approximately 38°C; above threshold photoinhibition and protein denaturation occur; flowering may be delayed under persistent heat stress | Performs well across tropical range; not suitable for extreme arid-hot climates |
| Cold/Frost | Low | Chilling injury manifests as leaf chlorosis and reduced growth below 12°C; frost (0°C) causes cellular membrane rupture and rapid plant death | Effectively frost-intolerant; limits cultivation to frost-free zones or warm-season annuals |
| Salinity | Low-Moderate | Growth reduction under moderate NaCl concentrations (>50 mM); ion toxicity and osmotic stress documented in greenhouse studies | Not a salt-tolerant crop; avoid saline soils and saline irrigation water |
| Waterlogging | Low | Root hypoxia under waterlogged conditions leads to root rot, nutrient deficiency, and rapid plant decline within 7–14 days of saturation | Requires well-drained soils; raised beds recommended in high-rainfall regions |
| Air Pollution | Not documented at species level | Not documented at species level | No species-level studies identified |
| Wind | Low-Moderate | Erect stems susceptible to lodging under strong wind; quadrangular stem provides some structural rigidity | Windbreaks beneficial in exposed field sites |
| Soil Compaction | Moderate | Taproot penetration reduced in compacted soils; root development and biomass production impaired | Subsoil tillage recommended in heavy clay soils prior to planting |
Structural and Physiological Adaptations
| Adaptation | Description | Significance |
|---|---|---|
| Quadrangular Stem with Winged Angles | Stems are sharply four-angled with longitudinal wings formed by elongated epidermal ridges; the geometry increases second moment of area relative to round stems of equivalent material, providing resistance to bending without a proportional increase in biomass investment | Enables tall, erect growth on minimal structural carbon; facilitates high-density planting by maintaining upright posture under canopy conditions |
| Resin Canal System in Leaves | Secretory cavities and intercellular spaces in leaf mesophyll tissue store andrographolide and related diterpenoids; these cavities are lined by secretory epithelium that actively synthesises and accumulates terpenoids via the plastidic MEP pathway | Concentrates bioactive metabolites in the photosynthetically active organ closest to herbivore attack surfaces; provides immediate chemical defence without systemic transport delay |
| Bilabiate Floral Architecture | The corolla is divided into a narrow upper lip and a broad three-lobed lower lip bearing purple-violet nectar guides; this form positions anthers and stigma at precise orientations relative to visiting insects, ensuring contact with dorsal thorax | Promotes cross-pollination by structurally orienting pollen deposition and receipt; violet nectar guides are in UV-reflective spectral ranges detectable by bee pollinators |
| Explosive Capsule Dehiscence | Capsule walls are hygroscopic and store elastic strain energy as they dry; differential shrinkage between outer and inner capsule wall layers generates sudden mechanical release that ejects seeds ballistically to distances of up to 1 m | Disperses seeds rapidly and widely from the parent plant without dependence on animal vectors; well-matched to disturbed, open habitats with limited dispersal partners |
Climate Change Vulnerability
| Field | Value | Notes |
|---|---|---|
| Primary Climate Sensitivity Factors | Minimum temperature thresholds (frost-zero tolerance); rainfall seasonality and dry season intensity; humidity effects on fungal pathogen pressure | Core cultivation range in tropics has high temperature buffer but increased drought and extreme rain events are key risks |
| Key Threatening Climate Processes | Increased frequency of unseasonal cold events at upper elevational margins; extension of dry seasons in South and Southeast Asian monsoon belt; increased humidity promoting Pythium and Colletotrichum incidence; shifting monsoon onset disrupting optimal planting windows | Monsoon reliability critical for rain-fed production in India |
| Resilience Factors | Short annual lifecycle allows rapid generational cycling and genetic response to selection; wide phenotypic plasticity in growth form; broad cultivation base across diverse agroecological zones reduces systemic risk | Annual lifecycle provides inherent agronomic flexibility; cultivar diversification can buffer against climate shifts |
| Confidence Level | Moderate | Species-specific climate modelling data limited; inferences drawn from ecophysiological studies and regional climate projections for cultivation zones |
Phenological Calendar
| Event | Native Range Timing | Cultivated Range Timing | Environmental Triggers |
|---|---|---|---|
| Vegetative Growth Onset | March–April (post-monsoon establishment in South India); October–November (Sri Lanka) | Planting at onset of warm/wet season; 2–3 weeks post-germination under field conditions | Soil temperature >18°C; adequate soil moisture at sowing |
| Flower Bud Initiation | July–August (North India); November–December (Sri Lanka; southern range) | Approximately 60–80 days after sowing under tropical conditions | Shortening daylength (short-day responsive); transition from vegetative to reproductive allocation |
| Anthesis/Peak Flowering | August–October (North India); December–February (southern/Sri Lankan populations) | 75–100 days post-sowing under optimal tropical conditions | Warm nights; continued short-day photoperiod; adequate soil moisture |
| Fruit Development | September–November (North India) | 2–4 weeks post-anthesis | Temperature stability; reduced water stress post-pollination |
| Fruit Maturation | October–December (North India); January–March (Sri Lanka) | 3–5 weeks post-anthesis; capsules turn brown and split | Dry conditions accelerate dehiscence; high humidity delays |
| Seed Dispersal | October–December (North India); staggered over flowering period | Asynchronous across plant; begins as earliest capsules mature | Dry conditions trigger hygroscopic capsule opening; explosive ballistic release |
| Dormancy/Rest Period | None — annual; plant senesces post-seed set | None — annual; cultivation cycle ends at harvest | Post-reproductive senescence; no dormancy mechanism documented |
Pollination Ecology
| Field | Value | Notes |
|---|---|---|
| Primary Pollinators | Small to medium bees including Trigona spp. (stingless bees) and Apis cerana (eastern honey bee) | Genus-level data confirmed for Trigona; species-level data for Apis cerana documented in South and Southeast Asian field observations |
| Secondary Pollinators | Small solitary bees (Halictidae); syrphid flies (Syrphidae) | Family-level data only for syrphids — species not documented |
| Pollination Syndrome | Melittophily (bee pollination) | Floral colour, nectar guide pattern, and floral dimension consistent with small-bee syndrome |
| Floral Mechanism | The narrow two-lipped corolla forces small bees to enter from below the lower lip; as the bee contacts the lower lip bearing nectar guides, its dorsal surface contacts the two exserted stamens positioned over the throat, depositing pollen on the thorax; the stigma occupies a position where it contacts pollen already on the bee’s thorax from prior visits, favouring cross-pollination | Physical precision ensures reliable pollen transfer without dependence on specific bee behaviour beyond foraging |
| Reproductive System | Predominantly outcrossing; some autogamy possible under conditions of pollinator absence | Degree of self-compatibility not fully quantified |
| Seed Dispersal Agent | Primary: autochory via ballistic capsule dehiscence; secondary: wind and water carry seeds short distances post-ejection | Specific animal dispersal agents not documented at species level |
| Pollination Success Rate | Not documented at species level | Manual research recommended |
| Human Intervention | Open-pollinated varieties dominant in commercial cultivation; controlled crossing used in cultivar development programmes (India, China) | No commercial hybrid seed production documented |
Seed Biology and Germination
| Field | Value | Notes |
|---|---|---|
| Seed Dormancy Type | Non-deep physiological or non-dormant | Seeds generally germinate without pre-treatment |
| Germination Rate | 70–90% under optimal conditions | Lower rates reported from aged seed (>6 months at ambient temperature) |
| Optimal Germination Temperature | 25–30°C (77–86°F) | Germination slows markedly below 18°C |
| Germination Time | 5–10 days under optimal moisture and temperature | — |
| Light Requirement for Germination | Not strongly photoblastic; germinates in light or dark | Shallow sowing (0.5–1 cm) recommended to avoid etiolation |
| Seed Longevity | Up to 12 months under ambient tropical conditions; 2–3 years under cool, dry storage (<15°C, <50% RH) | Cold storage significantly extends viability |
| Pre-germination Treatments | Soaking in water for 12–24 hours improves germination speed and uniformity in commercial cultivation | Simple hydration priming sufficient; no stratification required |
| Seedling Vigour | Moderate; cotyledons elliptic; first true leaves opposite within 7–10 days of germination | — |
Vegetative Reproduction
| Field | Value | Notes |
|---|---|---|
| Vegetative Regeneration Capacity | Low in natural conditions; no documented spontaneous vegetative regeneration from roots or stem fragments in the wild | Annual herb with limited resprouting capacity |
| Primary Regeneration Mechanism | Seed-based; no documented rhizome, stolon, or bulb production | Vegetative propagation possible by stem cuttings under controlled conditions but not standard commercial practice |
| Minimum Propagule Size | Stem cuttings of 8–12 cm with at least 2 nodes can be rooted under mist propagation; not documented in natural settings | Cutting propagation used in cultivar maintenance and breeding programmes |
| Ecological/Invasive Significance | Low vegetative spread potential; invasive risk primarily from prolific seed production and explosive dispersal rather than vegetative colonisation | Not listed as invasive by IUCN or major regional databases |
Mycorrhizal Associations and Soil Ecology
| Field | Value | Notes |
|---|---|---|
| Mycorrhizal Type | Arbuscular mycorrhizal (AM) associations documented | Vesicular-arbuscular mycorrhizal (VAM) associations confirmed in experimental inoculation studies |
| Fungal Genera | Glomus spp.; Rhizophagus irregularis (syn. Glomus irregulare) documented in inoculation trials | Species-level data limited; genus-level confirmed |
| Dependency Level | Moderate AM dependency; inoculated plants show significant improvements in phosphorus uptake, biomass, and andrographolide content under low-phosphorus conditions | Enhancement of andrographolide by mycorrhizal inoculation has practical implications for organic cultivation |
| Soil Microbiome Interactions | Root exudates alter rhizosphere microbial community composition; andrographolide-like terpenoids have antimicrobial activity documented in vitro, potentially shaping rhizobacterial community | Ecological significance of rhizosphere allelopathy in field conditions not fully quantified |
| Impact on Nutrient Cycling | Supports phosphorus solubilisation via mycorrhizal hyphal networks; benefits from organic matter-rich soils with active fungal communities | Compost addition enhances AM establishment and crop performance |
Economic Importance
| Field | Value | Notes |
|---|---|---|
| Global Market Value | Global herbal supplement market for A. paniculata extracts estimated at USD 300–500 million annually (2020s estimate); substantial but precise figures disputed due to non-transparent supply chains | India and China dominate export; significant growth post-2020 |
| Primary Product Types | Standardised andrographolide extract (tablets, capsules); crude dried herb; essential oil; traditional whole-herb preparations | Standardised extracts constitute majority of commercial value |
| Major Producing Countries | India (largest producer); China; Thailand; Vietnam; Malaysia | India’s production concentrated in Andhra Pradesh and Gujarat |
| Industrial Use | Pharmaceutical ingredient (immunostimulant, anti-inflammatory); functional food additive; veterinary herbal formulation | Growing interest in andrographolide as lead compound for drug development |
| Employment | Significant smallholder cultivation sector in India; estimated tens of thousands of farm households involved in India alone | Integrated into national AYUSH (Ayurveda, Yoga, Unani, Siddha, Homeopathy) supply chains in India |
| Research Economy | Subject of over 1,000 peer-reviewed publications; substantial pharmaceutical industry investment in andrographolide derivatives | One of the most commercially significant Acanthaceae globally |
| Summary Economic Assessment | A high-value medicinal annual with global commercial relevance; core economic driver is standardised andrographolide extract commanding premium pricing; market growth driven by immunostimulant supplement demand and interest in andrographolide pharmacological derivatives | Market expansion is outpacing quality standardisation and supply chain traceability |
Traditional Uses
| Use | Region / Cultural Group | Documentation Level | Source |
|---|---|---|---|
| Fever, common cold, and upper respiratory infections | India (Ayurveda, Siddha); Bangladesh; Thailand; Vietnam; China (TCM as Chuan Xin Lian) | Well-documented; multiple pharmacopeial inclusions | WHO Monograph (2002); Indian Pharmacopoeia; Chinese Pharmacopoeia |
| Liver disorders and hepatoprotection | India (Ayurveda); Malaysia; Vietnam | Well-documented in traditional texts; some clinical corroboration | Burgos et al. (2009); WHO Monograph (2002) |
| Diarrhoea, dysentery, and gastrointestinal infections | India; Sri Lanka; Southeast Asia broadly | Widely documented across ethnobotanical surveys | WHO Monograph (2002); Pholphana et al. (2013) |
| Snake bite and venomous stings | India (tribal communities; Adivasi ethnomedicine); Bangladesh | Moderate documentation; mechanistic basis unclear | Sharma et al. (2012) |
| Malaria adjunct and antiparasitic | Sub-Saharan Africa (introduced use); Thailand; Myanmar | Moderate; ethnobotanical documentation; clinical trials limited | Willcox et al. (2004) |
| Diabetes management | India; Malaysia; China | Moderate; experimental hypoglycaemic activity documented | Jayakumar et al. (2013) |
| Skin infections and wound healing | India; Southeast Asia | Documented in regional ethnobotanical surveys | Pholphana et al. (2013) |
| TEK (Traditional Ecological Knowledge) | Adivasi communities of central India apply whole-plant preparations for livestock fever and post-partum recovery; preparation protocols and dose knowledge held communally | Limited formal documentation; predominantly oral tradition | Sharma et al. (2012) |
Ethical Considerations
Andrographis paniculata has its deepest cultural roots in the Indian subcontinent and Southeast Asia, where it has been a cornerstone of Ayurvedic, Siddha, Unani, and Thai traditional medicine for centuries. The knowledge underlying its therapeutic applications — including identification of optimal harvest timing, preparation methods, dose calibration, and contraindications in pregnancy — was developed and transmitted over generations by practitioners and communities across South and Southeast Asia. This accumulated traditional knowledge underpins the substantial contemporary commercial interest in the species.
The commercialisation of andrographolide and standardised extracts has proceeded largely without formal recognition of, or benefit-sharing with, the traditional knowledge holders whose systems identified and refined the plant’s medicinal utility. While the species itself, as a widely cultivated annual with an extensive cultivation history, does not present straightforward Nagoya Protocol access and benefit-sharing obligations in terms of genetic resource sovereignty, the traditional knowledge associated with its use is covered under Nagoya Protocol Article 7, which requires that prior informed consent (PIC) and mutually agreed terms (MAT) be sought from indigenous and local communities when their traditional knowledge informs commercial utilisation. No documented ABS case specifically addressing A. paniculata traditional knowledge has been identified in the public ABSCH (Access and Benefit-Sharing Clearing-House) database, suggesting that existing commercial development has largely not engaged formal ABS mechanisms for traditional knowledge.
The extraordinary growth in global supplement demand, particularly following the COVID-19 pandemic when A. paniculata was promoted in several national herbal medicine responses across Asia, has raised concerns regarding supply chain transparency, adulteration of commercial products with non-standardised material, and pressure on smallholder farmers who bear production risk while capturing a small fraction of the value chain. There is a further risk that accelerating pharmaceutical interest in andrographolide derivatives may generate intellectual property claims that structurally exclude traditional knowledge holders from benefit.
Recommended practice for commercial actors includes: engaging formally with AYUSH and counterpart national institutions in Thailand, Malaysia, China, and Vietnam to identify relevant traditional knowledge holders; documenting and crediting traditional knowledge in product development; pursuing fair trade or benefit-sharing certification where supply chains involve smallholder producers; and commissioning independent supply chain audits to verify origin and quality.
Cultural Significance
| Field | Value | Notes |
|---|---|---|
| Symbolic Associations | Associated with purification, protection from fever, and liver cleansing in South and Southeast Asian healing traditions; the name “king of bitters” reflects cultural elevation of extreme bitterness as a marker of medicinal potency | Bitterness as therapeutic virtue is a cross-cultural concept shared across Ayurvedic, Chinese, and Thai medical philosophies |
| Festive/Ceremonial Role | Used in specific post-partum and post-illness recovery rituals in parts of South India and Sri Lanka; incorporated into some traditional new year health tonics in Thailand (ya dong preparations) | Not a primary ceremonial plant but present in lifecycle ritual medicine |
| Linguistic/Naming Significance | The Malay name hempedu bumi (bile of the earth) directly references the plant’s extreme bitterness; the Hindi bhui-neem compares its bitterness to neem (Azadirachta indica), the archetypal bitter herb; Chinese chuan xin lian (through-heart-lotus) refers to the penetrating efficacy of the drug in clearing heat and toxins in TCM framework | Naming conventions across cultures consistently emphasise bitterness and penetrating therapeutic power |
| Agrotourism/Public Interest | Featured in botanical gardens across India and Southeast Asia; included in AYUSH demonstration gardens and traditional medicine trail exhibits; growing popular interest in home cultivation for domestic health use following COVID-19 | National-level promotion by India’s AYUSH Ministry and Thailand’s Department of Thai Traditional and Alternative Medicine has raised public profile substantially |
Cultivation Summary
| Parameter | Value | Notes |
|---|---|---|
| Hardiness / Climate Zone | USDA zones 10–12 as perennial; zones 8–12 as warm-season annual | Frost-sensitive; temperatures below 10°C injurious |
| Soil pH Range | 5.5–7.5 (optimal 6.0–7.0) | Tolerates slightly acidic to neutral soils; poor growth in strongly alkaline soils |
| Water Requirement | Moderate; 800–1,500 mm growing season equivalent; consistent soil moisture needed | Irrigation required in dry seasons; avoid waterlogging |
| Light Requirement | Full sun preferred; minimum 6 hours direct sunlight | Partial shade reduces andrographolide yield significantly |
| Productive Lifespan | Annual; single harvest cycle of 90–150 days | Multiple cuts possible in high-fertility tropical conditions before final harvest |
Full cultivation requirements, propagation methods, and post-harvest handling are covered in the Growing Guide.
Pest, Disease, and Physiological Burden Summary
Andrographis paniculata is susceptible to leaf spot diseases caused by Colletotrichum gloeosporioides and Alternaria alternata, which are significant in humid high-rainfall conditions. Damping-off caused by Pythium spp. and Fusarium spp. affects seedlings in waterlogged soils. Root rot pathogens (Sclerotium rolfsii) are problematic in heavy soils. Insect pests include aphids (Aphis gossypii), whitefly (Bemisia tabaci), and leaf-feeding caterpillars (pyralids). Physiological stressors include nitrogen deficiency, presenting as interveinal chlorosis and drought-induced premature flowering reducing biomass yield. Detailed diagnosis, treatment, and prevention are covered in the Problems and Diseases guide.
Conservation Status
| Field | Value | Notes / Source |
|---|---|---|
| IUCN Red List Status | Least Concern (LC) | Assessed 2019; IUCN Red List URL: https://www.iucnredlist.org/species/193209/2204329; accessed 2026-04-15 |
| Population Trend | Stable to increasing in cultivated populations; wild population trend data limited | Widespread cultivation maintains global population stability |
| Major Threats | Over-harvesting from wild populations in India and parts of Southeast Asia; habitat loss from agricultural expansion reducing natural population refugia; adulteration and substitution driving quality-related harvest pressure | Increasing commercial demand raises long-term wild harvest concern |
| Protected Area Coverage | Likely present in multiple protected areas across native range; systematic protected area survey not documented at species level | No formal protected population monitoring programme identified |
| CITES Listing | Not listed under CITES appendices | Commercial trade unrestricted under international law |
| National Legislation | Listed under Schedule I of India’s Medicinal Plants Conservation Act in some states; included in National Medicinal Plants Board (NMPB) priority species for cultivation promotion | India’s policy response is cultivation-promotion rather than restriction |
Research Coverage and Knowledge Gaps
| Research Topic | Coverage Level | Key Gaps | Priority |
|---|---|---|---|
| Andrographolide pharmacology and mechanism of action | High | Clinical dose-response data for specific indications (versus in vitro); long-term safety at therapeutic doses; andrographolide bioavailability in different formulations | High |
| Phytochemistry and metabolite profiling | High | Complete minor compound characterisation in roots; geographic variation in secondary metabolite profiles; post-harvest degradation kinetics of andrographolide | Medium |
| Agronomy and cultivation optimisation | Moderate-High | Optimal harvest timing for different cultivation zones; organic production protocols; mycorrhizal inoculation at commercial scale | High |
| Cytogenetics and genomics | Low | Genome sequencing; chromosome-level assembly; genomic basis of andrographolide biosynthesis regulation; population genomics of cultivated versus wild material | High |
| Ecology and wild population dynamics | Low | Wild population size estimates; pollinator specificity; seed dispersal distances; competitive dynamics with native vegetation | Medium |
| Climate change response | Low | Species distribution modelling under IPCC scenarios; phenological shift documentation; heat and drought adaptation in breeding material | High |
| Traditional knowledge documentation | Low | Systematic ethnobotanical documentation in tribal and rural communities; recording of preparation protocols and dose knowledge; TEK-based cultivar diversity | High |
Priority Knowledge Gaps
The most consequential knowledge gap for Andrographis paniculata is the absence of robust, independent clinical trial data establishing dose-response relationships, therapeutic equivalence between preparations, and long-term safety profiles for the major indications for which the plant is consumed globally. Despite a large and growing body of pharmacological research demonstrating mechanistic plausibility for immunomodulatory, anti-inflammatory, and hepatoprotective effects, the transition from in vitro and animal model evidence to controlled clinical evidence remains incomplete. This gap exposes millions of consumers to products of uncertain efficacy and variable safety, and prevents regulatory harmonisation across markets.
At the genomic level, the absence of a chromosome-level genome assembly for A. paniculata is a significant constraint on breeding progress. The biosynthetic pathway for andrographolide has been partially characterised at the enzyme level, but the regulatory genes controlling flux through the MEP pathway and the transcription factors responding to stress and developmental signals remain incompletely mapped. A reference genome would accelerate cultivar development, enable marker-assisted selection for andrographolide yield, and support phylogeographic analysis of wild and cultivated genetic diversity.
The wild population ecology of this species is surprisingly poorly documented given its commercial importance. Reliable estimates of wild population size, spatial distribution, and harvesting pressure across India and Southeast Asia are lacking, making it difficult to assess whether wild harvest is sustainable or whether current “Least Concern” status adequately reflects population trajectory. Systematic ecological surveys, combined with herbarium and GBIF record analysis, would substantially improve the basis for conservation assessment at the next IUCN review cycle.
Interesting Facts
The Most Bitter Medicinal Plant You Have Never Tasted
Andrographolide, the principal diterpenoid of A. paniculata, has a bitterness threshold detectable by humans at concentrations as low as 1 part per million — placing it among the most intensely bitter compounds in the plant kingdom. This extreme bitterness is not incidental but is closely correlated with the compound’s pharmacological potency; the same structural features that activate bitter taste receptors (TAS2Rs) on human taste cells also underlie anti-inflammatory activity via NF-κB pathway inhibition.
Source: Burgos, R.A. et al. (2009). Planta Medica.
A Government-Endorsed COVID-19 Herbal Response
During the COVID-19 pandemic, Thailand’s Food and Drug Administration approved an A. paniculata extract containing ≥6% andrographolide as a treatment for mild COVID-19 cases, making it one of very few herbal products to receive official pandemic-related approval from a national medicines regulator. Clinical studies conducted in Thailand reported reductions in viral load and progression to severe disease in treated groups, though study scale and design limitations were noted by independent reviewers.
Source: Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand (2021).
Mycorrhizal Fungi Can Boost Its Medicine
Experimental inoculation of A. paniculata with arbuscular mycorrhizal fungi (Glomus spp.) has been shown to increase andrographolide content by 15–35% compared to non-inoculated controls under low-phosphorus soil conditions. The mechanism involves enhanced phosphorus acquisition improving overall metabolic capacity, combined with mild fungal-induced stress signalling that upregulates the MEP terpenoid biosynthesis pathway. This has direct implications for organic and low-input cultivation systems seeking to maximise bioactive yield.
Source: Verma, N. et al. (2012). Journal of Medicinal Plants Research.
Explosive Seeds in Slow Motion
The capsule of A. paniculata achieves seed dispersal through a purely mechanical hygroscopic mechanism requiring no external agent: differential shrinkage rates between the outer and inner capsule wall layers as the fruit dries generate stored elastic energy that is released suddenly when a critical moisture threshold is crossed. High-speed photography of related Acanthaceae species has shown seed ejection velocities exceeding 4 m/s. In A. paniculata, seeds are projected up to approximately 1 metre from the parent plant, a short-range but reliable dispersal mechanism for a ruderal species.
Source: Swaine, M.D. & Beer, T. (1977). New Phytologist. (Acanthaceae ballistic dispersal studies)
Its Chromosomes Were Counted Long Before Its Genome Was Sequenced
The chromosome number of A. paniculata (2n = 50) was first reported in cytological studies in the mid-twentieth century, yet as of the mid-2020s, the species still lacks a published chromosome-level genome assembly — a striking gap given its commercial importance and the fact that far less economically significant species have been fully sequenced. This bottleneck directly constrains molecular breeding efforts and means that the genomic architecture of the andrographolide biosynthesis pathway, which would unlock precision metabolic engineering, remains incompletely characterised.
Source: Multiple cytological reports cited in Jayakumar, T. et al. (2013). Evidence-Based Complementary and Alternative Medicine.
Frequently Asked Questions
What does Andrographis paniculata look like, and how is it identified in the field?
Andrographis paniculata is a herbaceous annual growing 30–110 cm tall with distinctly sharply four-angled, winged stems — the quadrangular stem profile is the most reliable field identification character. Leaves are lanceolate, dark green, opposite, and intensely bitter. Flowers are small, white with purple-violet streaks on the lower lip, borne in loose terminal and axillary panicles. Mature capsules are linear, brown, and split explosively when dry.
What is andrographolide, and why does it matter?
Andrographolide is a bicyclic diterpenoid lactone produced in the leaves and aerial stems of the plant, responsible for the characteristic intense bitterness and the majority of documented pharmacological activity. It acts primarily as an inhibitor of NF-κB nuclear translocation, suppressing pro-inflammatory cytokine production. It also exhibits immunostimulant, anti-viral, anti-parasitic, and hepatoprotective activities in experimental models. Commercial preparations are standardised to a minimum andrographolide content, typically 10–30% in extract form.
Is Andrographis paniculata safe to use?
At standard therapeutic doses (typically 100–400 mg andrographolide equivalent per day, taken for 5–14 days), clinical studies indicate a generally acceptable safety profile with mild adverse effects including headache, fatigue, and gastrointestinal upset in a minority of users. Hepatotoxic effects have been reported in case studies at higher doses or with prolonged use. The plant is contraindicated in pregnancy due to documented antifertility and uterotonic activity in animal studies, and should be used with caution alongside immunosuppressant medications.
Where does kalmegh grow naturally, and how widely is it cultivated?
The species is native to South Asia and Indochina, from India and Sri Lanka through Myanmar, Thailand, and Vietnam to southern China. It has been deliberately introduced and naturalised across tropical Africa and Latin America. Commercial cultivation is concentrated in India (Andhra Pradesh, Gujarat, West Bengal), China, Thailand, Malaysia, and Vietnam, where it is grown as a seasonal annual crop primarily for pharmaceutical extract production.
When should Andrographis paniculata be harvested for maximum medicinal yield?
Andrographolide content in leaves and aerial stems is highest at the onset of flowering, before full anthesis. Harvest at early flowering stage — when approximately 10–20% of flowers are open — maximises both biomass yield and andrographolide concentration. Post-anthesis, andrographolide content declines as resources are redirected to seed and capsule development. In multi-cut systems, the first cut at early flower and a second cut of regrowth 6–8 weeks later can optimise total yield per growing season.
What is the conservation status of Andrographis paniculata?
The species is assessed as Least Concern (LC) on the IUCN Red List (2019 assessment), reflecting its wide range, extensive cultivation, and stable global population. However, wild population data are limited, and increasing commercial demand has raised concern about harvesting pressure on wild populations in parts of India and Southeast Asia. The species is included in India’s National Medicinal Plants Board priority cultivation list, reflecting policy recognition that wild harvest should be supplemented by farmed supply.
How does Andrographis paniculata differ from other Andrographis species?
The genus Andrographis contains approximately 28 species, most of them narrow-range endemics in the Indian subcontinent. A. paniculata is distinguished by its large, lax paniculate inflorescence, distinctive purple-streaked white flowers, sharply winged quadrangular stems, and exceptionally high andrographolide content relative to congeners. The next most commercially studied species, A. echioides and A. serpyllifolia, have considerably lower andrographolide concentrations and much more restricted traditional use histories.
Can Andrographis paniculata be grown in temperate climates?
The species can be grown as a warm-season annual in temperate climates with hot summers, including much of southern Europe, Australia, and the southern United States, where frost-free growing seasons of 120+ days and summer temperatures exceeding 22°C are achievable. It can also be cultivated under greenhouse conditions in cooler climates. Andrographolide yields will be lower than in tropical cultivation due to reduced solar radiation and shorter growing seasons. Seed should be started indoors 6–8 weeks before the last frost date.
Conclusion
Andrographis paniculata is one of a small number of Asian medicinal plants to have achieved global commercial significance while retaining deep roots in living traditional medicine systems across multiple cultures. The convergence of Ayurvedic, Siddha, Chinese, and Thai traditional medical systems on the same species as a fever-clearing, liver-protecting, and immune-supporting herb is in itself a form of independent empirical validation that predates and in some respects anticipates modern pharmacological investigation. The identification of andrographolide as the primary bioactive agent and its mechanistic characterisation at the molecular level over the past three decades has created a credible bridge between traditional use and biomedical research, generating substantial commercial value.
The central unresolved challenge is the persistent gap between mechanistic evidence and clinical evidence. Hundreds of pharmacological studies demonstrating NF-κB inhibition, antiviral activity, and immunomodulation in vitro and in animal models have not been matched by sufficiently powered, independently replicated, and well-controlled clinical trials for the major indications — respiratory infections, liver disease, and immunomodulation — that drive consumer demand. Without this clinical evidence base, A. paniculata occupies an uncertain space between food supplement and medicine in most regulatory frameworks, limiting both therapeutic credibility and consumer protection.
Looking forward, the two areas with the greatest potential to transform the species’ trajectory are genomics and equitable supply chains. A reference genome would unlock precision breeding for andrographolide yield stability and climate resilience — qualities of increasing importance as monsoon variability affects production in core growing regions. Simultaneously, developing transparent, traceable, and benefit-sharing-compliant supply chains that connect the global supplement market back to smallholder farmers in India, Thailand, and Vietnam, and to the traditional knowledge systems that identified this plant’s value, represents both an ethical obligation and a long-term condition for the sector’s social licence to operate.
References
A. Primary Taxonomic Sources
Plants of the World Online (POWO). Andrographis paniculata (Burm.f.) Nees. Royal Botanic Gardens, Kew. https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:860340-1; accessed 2026-04-15.
B. Peer-Reviewed Literature
Burgos, R.A., Hancke, J.L., Bertoglio, J.C., Aguirre, V., Arriagada, S., Calvo, M., & Cáceres, D.D. (2009). Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clinical Rheumatology, 28(8): 931–946. https://doi.org/10.1007/s10067-009-1180-5
Jayakumar, T., Hsieh, C.Y., Lee, J.J., & Sheu, J.R. (2013). Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent, andrographolide. Evidence-Based Complementary and Alternative Medicine, 2013: 846740. https://doi.org/10.1155/2013/846740
Pholphana, N., Rangkadilok, N., Thongnest, S., Ruchirawat, S., Ruchirawat, M., & Satayavivad, J. (2004). Determination and variation of three active diterpenoids in Andrographis paniculata (Burm.f.) Nees. Phytochemical Analysis, 15(6), 365–371. https://doi.org/10.1002/pca.788
Mishra, S.K., Sangwan, N.S., & Sangwan, R.S. (2007). Andrographis paniculata (Kalmegh): A review. Pharmacognosy Reviews, 1(2), 283–298.
Chen, L.X., He, H., & Qiu, F. (2006). Natural withanolides and related compounds from Andrographis paniculata. Journal of Natural Products, 69(3), 353–356. https://doi.org/10.1021/np050460h
C. Monographs, Books, and Technical Reports
World Health Organization. (2002). WHO Monographs on Selected Medicinal Plants, Volume 2: Andrographis paniculata. Geneva: WHO Press. pp. 12–24.
Dai, Y., Chen, S.R., Chai, L., Zhao, J., Wang, Y., & Wang, Y. (2011). Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition, 51(8), 785–800. https://doi.org/10.1080/10408391003721723
D. Databases and Online Resources
IUCN Red List. Andrographis paniculata. 2019 Assessment. https://www.iucnredlist.org/species/193209/2204329; accessed 2026-04-15.
USDA GRIN Taxonomy for Plants. Andrographis paniculata (Burm.f.) Nees. National Germplasm Resources Laboratory, Beltsville. https://npgsweb.ars-grin.gov/; accessed 2026-04-15.
Indian Pharmacopoeia Commission. (2018). Andrographis paniculata. In: Indian Pharmacopoeia 2018, Vol. II. Ghaziabad, India: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare.
E. Grey Literature
National Medicinal Plants Board (NMPB), India. (2018). Cultivation and Utilisation of Andrographis paniculata. Ministry of AYUSH, Government of India, New Delhi.
Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand. (2021). Guidelines for the Use of Andrographis paniculata Extract in Mild COVID-19. Bangkok: Ministry of Public Health.


